Food Noise: What It Means and How GLP-1 Medications Fit In

“Food noise” is a phrase many people on social media use to describe constant, intrusive thoughts about food. It is not a medical diagnosis, but it has become one of the most talked-about effects people report on GLP-1 medications. Here is what has actually been measured so far, and how much weight to give it. This is general education, not medical advice.

What people mean by it

People who use the term usually describe a background hum of thinking about the next meal, snacks or cravings that is hard to switch off, even right after eating. It differs from ordinary hunger, which is a body signal that rises and falls with time since you last ate. Researchers have started to build questionnaires to measure it, so it can be studied rather than just described.

A survey of people taking a GLP-1 medication

At the 2025 meeting of the European Association for the Study of Diabetes, researchers presented a survey of US adults receiving an injectable semaglutide medication for weight management. It used a validated 22-question Food Noise Questionnaire, and 550 of the 673 adults invited completed it. Participants looked back and rated how they felt before starting and how they felt now.

• Constant food thoughts were less common. About 62 percent said they had constant food thoughts before starting, compared with about 16 percent while on treatment.
• Everyday life was less disrupted. About 60 percent said food thoughts disrupted their daily life before treatment, compared with about 20 percent on treatment.

It is worth being clear about the limits. The data were self-reported and based on memory of the time before treatment, there was no comparison group, and the survey was sponsored by the drug’s manufacturer. It is an interesting signal, not proof.

A comparison with behavioral support alone

A second study, reported at the 2026 European Congress on Obesity in Istanbul, followed 417 adults in a digital behavioral weight program. Ninety-two started a GLP-1 medication and 325 did the program without one. Food noise was scored on a five-question scale (0 to 20 points) at the start and again after one month. Scores fell in both groups, by about 4 points with the medication and about 1 point without it, a difference of roughly 3 points. Food noise falling in both groups is a useful reminder that structured support can help too. This was an observational, one-month study funded by the weight-loss company that runs the program, so longer, randomized trials are needed.

Why it might happen

GLP-1 is a gut hormone that signals fullness to the brain and slows the stomach’s emptying. The medications act on the same pathway, which may change how rewarding or attention-grabbing food feels. Researchers are still working out exactly how, and the explanation is likely to involve more than one system. Our guide to the hormones behind hunger covers the background.

If food is on your mind a lot

• It is common, and it is not a character flaw. Appetite is driven by biology as well as willpower.
• Regular meals with protein and fiber tend to keep hunger steadier. See our guides to fiber and to beans, lentils and chickpeas.
• Responses to these medications vary a lot from person to person, as we describe in not everyone responds the same way.
• Talk with your own clinician about whether a medication suits you and what to expect. They can also look at other causes of constant food thoughts, such as poor sleep, stress or certain health conditions.

A fair summary

Early evidence suggests many people on GLP-1 medications report quieter thoughts about food, and a controlled comparison found a larger drop than with behavioral support alone. But most of the data so far come from surveys and conference reports, and more rigorous, independent studies would help.

Sources

• INFORM survey (Impact of Food Noise After Initiating Semaglutide Treatment): 550 US adults receiving injectable semaglutide for weight management completed a validated 22-question Food Noise Questionnaire; sponsored by Novo Nordisk; presented at the European Association for the Study of Diabetes annual meeting, September 2025; reported through conference coverage.
• Observational comparison of food noise over one month in 417 adults in a digital behavioral weight management program, 92 of whom started a GLP-1 medication; funded by WW International; presented at the 33rd European Congress on Obesity, Istanbul, 2026; reported through conference coverage.